According to a post on the FDA’s website, Pyxis Oncology’s treatment of pancreatic cancer was granted orphan designation. Reference Link
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PYXS:
- Fifteen new option listings on April 12th
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pyxis Stock Is Up 170% This Week. How Much Higher Can It Go?
- Pyxis Oncology Blasts Up to Hit New Highs
- Pyxis Oncology Reports Financial Results for the Fiscal Year Ended December 31, 2022, and Provides Corporate Update